Cost-effectiveness analyses of 20-valent pneumococcal conjugate vaccine in children and adults: A narrative review

Cost-effectiveness analyses of 20-valent pneumococcal conjugate vaccine in children and adults: A narrative review

Many pneumococcal vaccines have been developed. Economic evaluation provides a framework to inform decision-making. Cost-effectiveness analysis (CEA) studies on 20-valent pneumococcal conjugate vaccine (PCV20) have been published. We introduce the concept of health economics and the basic framework...

Full description

Saved in:
Bibliographic Details
Main Authors: Aiko Shono, Shu-Ling Hoshi, Masahide Kondo
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Pneumococcal vaccine
PCV20
PCV
economic evaluation
cost-effective analysis
cost-utility analysis
Online Access:https://www.tandfonline.com/doi/10.1080/21645515.2025.2525619
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://www.tandfonline.com/doi/10.1080/21645515.2025.2525619

Similar Items